Mark R. Eckman
-
- Antibiotic Use and Resistance 4
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 2
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 3
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 3
-
- Fungal Infections and Studies 5
-
- Oral microbiology and periodontitis research 1
-
- Enterobacteriaceae and Cronobacter Research 1
-
- Infectious Diseases and Mycology 1
- Co-authors
- Joel RuskinWilliam FarrerRobert A. DuncanDavid M. ShlaesDale N. GerdingJohn E. McGowanStuart B. LevyDonald L. Bornstein
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- Clinical Infectious Diseases (3 papers)Infection Control and Hospital Epidemiology (2 papers)JAMA (1 paper)
- Partner nations
- United States
In The Last Decade
Mark R. Eckman
13 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 544
- Molecular Medicine 252
- Critical Care and Intensive Care Medicine 225
- Clinical Biochemistry 253
- Infectious Diseases 519
Countries citing papers authored by Mark R. Eckman
This map shows the geographic impact of Mark R. Eckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Eckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Eckman more than expected).
Fields of papers citing papers by Mark R. Eckman
This network shows the impact of papers produced by Mark R. Eckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Eckman. The network helps show where Mark R. Eckman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark R. Eckman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 1 | |
| 2 | 1997 | 159 | |
| 3 | Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitalsbreakdown → | 1997 | 612 |
| 4 | 1997 | 171 | |
| 5 | Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? | 1994 | 180 |
| 6 | 1990 | 64 | |
| 7 | 1984 | 4 | |
| 8 | 1983 | 29 | |
| 9 | 1982 | 28 | |
| 10 | 1981 | 38 | |
| 11 | 1979 | 40 | |
| 12 | 1975 | 3 | |
| 13 | 1975 | 43 |
About Mark R. Eckman
Mark R. Eckman is a scholar working on Applied Microbiology and Biotechnology, Microbiology, Clinical Biochemistry, Molecular Medicine and Small Animals, having authored 13 papers that have together received 1.4k indexed citations. Recurring topics across this work include Fungal Infections and Studies (5 papers), Antibiotic Use and Resistance (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Antifungal resistance and susceptibility (3 papers), Antibiotic Resistance in Bacteria (2 papers), Oral microbiology and periodontitis research (1 paper), Enterobacteriaceae and Cronobacter Research (1 paper) and Infectious Diseases and Mycology (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (544 citations), Molecular Medicine (252 citations), Critical Care and Intensive Care Medicine (225 citations), Clinical Biochemistry (253 citations) and Infectious Diseases (519 citations). Mark R. Eckman has collaborated with scholars based in United States. Frequent co-authors include Joel Ruskin, William Farrer, Robert A. Duncan, David M. Shlaes, Dale N. Gerding, John E. McGowan, Stuart B. Levy, Donald L. Bornstein, Víctor Lorian and Joseph F. John. Their work appears in journals such as Clinical Infectious Diseases, Infection Control and Hospital Epidemiology, JAMA, Journal of Clinical Microbiology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.